Nasdaq
KROS
Keros Therapeutics, Inc.
- Health Care
- Listed 2020
- 1 day
- +6.6%
- 1 month
- −8.6%
- 1 year
- −26.1%
$10.65 · Mkt cap $211M · P/E 4.63
At the 6 Aug 2026 close
Nasdaq
Keros Therapeutics, Inc.
$10.65 · Mkt cap $211M · P/E 4.63
At the 6 Aug 2026 close
Keros Therapeutics, Inc. trades under the ticker KROS on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2020. Its market capitalisation is $211M. The last closing price was $10.65, on 6 Aug 2026. It trades at 4.63 times its last reported annual diluted earnings per share. Over the past year the share price is −26.1%, and −8.6% over the past month. Returns are price returns and exclude dividends.
This page exists because KROS is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.